TRENTON, N.J. (AP) -- British drugmaker GlaxoSmithKline PLC is restructuring its U.S. operations, starting with reducing its U.S. sales force by 1,000, following many of its top competitors in eliminating sales jobs.
The world's No. 2 drugmaker by revenue also will switch from having dual U.S. headquarters, in Philadelphia and in Research Triangle Park, N.C., to operating just the North Carolina headquarters.
U.S.-traded shares of GlaxoSmithKline fell $3.23, or 8 percent, to close at $36.96 Wednesday.
Spokeswoman Mary Anne Rhyne said that the headquarters change is meant to eliminate confusion and is largely symbolic. There are currently no plans to cut jobs or close offices in Philadelphia related to the headquarters move, she said.
"The goal is to build a business that's more streamlined, that's more customer focused, that meets the challenge of the current marketplace and is better prepared to manage the future portfolio of medicines," Rhyne said.
GlaxoSmithKline, the maker of antidepressant Wellbutrin and Requip for Parkinson's disease, currently has about 8,500 U.S. sales representatives, out of a total of 22,500 employees in the U.S. and 100,000 worldwide.
Police: Houston Found Dead in Her Hotel Room
Paul Suffers Narrow Loss to Romney in Maine
Recording Superstar Whitney Houston Dead at 48
Maine GOP Chairman Says Romney Wins Caucuses
Palin Brings Anti-Washington Message to CPAC
Obama Scraps Birth Control Mandate
US Airmen's Killer Sentenced to Life in Germany
Navy Names Ship for Gabrielle Giffords
Raw Video: Deadly Blasts in Syria
Romney Slams President Obama at CPAC
Gingrich: Pres. Obama 'waging War on Religion'
5 Killed in Wrong-way Crash on I-10 in La.
Uzbek Man Pleads Guilty in Plot to Kill Obama
Denver's Largest-Ever Drug Bust Nets Dozens
Marines: No Punishment for Nazi-like Flag
Vets Look to Translate Military Skills Into Jobs
Raw Video: School Bus Burst Into Flames
LA School Reopens Amid Sex Abuse Scandal
$25B Settlement Reached Over Foreclosure Abuses
Pentagon: Allow Women Closer to Front Lines
